| Dr Joseph Michael Mayland, DO | |
|
4300 Marketpointe Dr Ste 100, Bloomington, MN 55435-5435 | |
| (952) 835-9880 | |
| Not Available |
| Full Name | Dr Joseph Michael Mayland |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 21 Years |
| Location | 4300 Marketpointe Dr Ste 100, Bloomington, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679505093 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 45578 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carris Health Llc | Willmar, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Physicians Professional Association | 9537072657 | 205 |
News Archive
Virginia Tech researcher Pavlos Vlachos and his students in the College of Engineering have a tall order to tackle: Stem the grim progression of heart disease, which kills hundreds of thousands of people each year in the United States alone.
OmniLytics, Inc., a biotech company focused on developing safe and natural solutions for bacterial control, today announced final EPA registration for its AgriPhage-CMM bacterial control product.
Abbott Laboratories will soon acquire the biggest share of India's pharmaceuticals market, about 7%, when the company closes as early as next month on a $3.7 billion takeover of the drugs business of Piramal Healthcare Ltd
Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).
› Verified 7 days ago
| Entity Name | Emergency Physicians Professional Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801871934 PECOS PAC ID: 9537072657 Enrollment ID: O20031106000068 |
News Archive
Virginia Tech researcher Pavlos Vlachos and his students in the College of Engineering have a tall order to tackle: Stem the grim progression of heart disease, which kills hundreds of thousands of people each year in the United States alone.
OmniLytics, Inc., a biotech company focused on developing safe and natural solutions for bacterial control, today announced final EPA registration for its AgriPhage-CMM bacterial control product.
Abbott Laboratories will soon acquire the biggest share of India's pharmaceuticals market, about 7%, when the company closes as early as next month on a $3.7 billion takeover of the drugs business of Piramal Healthcare Ltd
Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).
› Verified 7 days ago
| Entity Name | Swift County-benson Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174529002 PECOS PAC ID: 8729069281 Enrollment ID: O20040528001145 |
News Archive
Virginia Tech researcher Pavlos Vlachos and his students in the College of Engineering have a tall order to tackle: Stem the grim progression of heart disease, which kills hundreds of thousands of people each year in the United States alone.
OmniLytics, Inc., a biotech company focused on developing safe and natural solutions for bacterial control, today announced final EPA registration for its AgriPhage-CMM bacterial control product.
Abbott Laboratories will soon acquire the biggest share of India's pharmaceuticals market, about 7%, when the company closes as early as next month on a $3.7 billion takeover of the drugs business of Piramal Healthcare Ltd
Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).
› Verified 7 days ago
| Entity Name | Ccm Health |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1720086028 PECOS PAC ID: 4284539453 Enrollment ID: O20060504000810 |
News Archive
Virginia Tech researcher Pavlos Vlachos and his students in the College of Engineering have a tall order to tackle: Stem the grim progression of heart disease, which kills hundreds of thousands of people each year in the United States alone.
OmniLytics, Inc., a biotech company focused on developing safe and natural solutions for bacterial control, today announced final EPA registration for its AgriPhage-CMM bacterial control product.
Abbott Laboratories will soon acquire the biggest share of India's pharmaceuticals market, about 7%, when the company closes as early as next month on a $3.7 billion takeover of the drugs business of Piramal Healthcare Ltd
Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).
› Verified 7 days ago
| Entity Name | Centracare Health System-nr Llc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1275872772 PECOS PAC ID: 3870739410 Enrollment ID: O20130426000215 |
News Archive
Virginia Tech researcher Pavlos Vlachos and his students in the College of Engineering have a tall order to tackle: Stem the grim progression of heart disease, which kills hundreds of thousands of people each year in the United States alone.
OmniLytics, Inc., a biotech company focused on developing safe and natural solutions for bacterial control, today announced final EPA registration for its AgriPhage-CMM bacterial control product.
Abbott Laboratories will soon acquire the biggest share of India's pharmaceuticals market, about 7%, when the company closes as early as next month on a $3.7 billion takeover of the drugs business of Piramal Healthcare Ltd
Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).
› Verified 7 days ago
| Entity Name | Centracare Health System-nr Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558600874 PECOS PAC ID: 3870739410 Enrollment ID: O20130515000683 |
News Archive
Virginia Tech researcher Pavlos Vlachos and his students in the College of Engineering have a tall order to tackle: Stem the grim progression of heart disease, which kills hundreds of thousands of people each year in the United States alone.
OmniLytics, Inc., a biotech company focused on developing safe and natural solutions for bacterial control, today announced final EPA registration for its AgriPhage-CMM bacterial control product.
Abbott Laboratories will soon acquire the biggest share of India's pharmaceuticals market, about 7%, when the company closes as early as next month on a $3.7 billion takeover of the drugs business of Piramal Healthcare Ltd
Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).
› Verified 7 days ago
| Entity Name | Carris Health Llc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1134632680 PECOS PAC ID: 7012274228 Enrollment ID: O20180111000831 |
News Archive
Virginia Tech researcher Pavlos Vlachos and his students in the College of Engineering have a tall order to tackle: Stem the grim progression of heart disease, which kills hundreds of thousands of people each year in the United States alone.
OmniLytics, Inc., a biotech company focused on developing safe and natural solutions for bacterial control, today announced final EPA registration for its AgriPhage-CMM bacterial control product.
Abbott Laboratories will soon acquire the biggest share of India's pharmaceuticals market, about 7%, when the company closes as early as next month on a $3.7 billion takeover of the drugs business of Piramal Healthcare Ltd
Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Michael Mayland, DO 301 Becker Ave Sw, Willmar, MN 56201-3302 Ph: (320) 235-4543 | Dr Joseph Michael Mayland, DO 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435-5435 Ph: (952) 835-9880 |
News Archive
Virginia Tech researcher Pavlos Vlachos and his students in the College of Engineering have a tall order to tackle: Stem the grim progression of heart disease, which kills hundreds of thousands of people each year in the United States alone.
OmniLytics, Inc., a biotech company focused on developing safe and natural solutions for bacterial control, today announced final EPA registration for its AgriPhage-CMM bacterial control product.
Abbott Laboratories will soon acquire the biggest share of India's pharmaceuticals market, about 7%, when the company closes as early as next month on a $3.7 billion takeover of the drugs business of Piramal Healthcare Ltd
Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).
› Verified 7 days ago
Rebecca Lynn Meyer, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 | |
Dr. Holly Lynn Schrupp Berg, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 Fax: 952-857-1554 | |
Andrew H Bauer, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 Fax: 952-857-1554 | |
Laura Kuhlman, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 | |
Elisabeth Marycke Vreede Greenberg, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 Fax: 952-857-1554 | |
Leonardo A Saavedra, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 Fax: 952-857-1554 | |
Dr. Ferris Yeh, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 Fax: 952-857-1554 |